Injective

Injective was born out of a mission to help businesses reduce reliance on debt financing and use receivables securitization as a better, low cost alternative. We are building category-leading asset-backed securitization technology for working capital raising and accessing of high-yielding, short term investment-grade securities that aligns with institutional market needs. Our technology integrates with a large ecosystem of securitization parties so that you can create a custom end-to-end solution. For businesses, Injective offers a lower cost source of working capital in comparison to other alternatives such as business loans. Your company – whether a startup, small, medium, or large – can use our platform to securitize its receivables to achieve significant cost savings. As an investor, access the most exclusive asset class – private market – and invest in an asset that has stable and attractive returns, short-term maturity, and low market correlation.